EE395 A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients With Inflammatory Bowel Disease in the United Kingdom
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.641
https://www.valueinhealthjournal.com/article/S1098-3015(22)02845-5/fulltext
Section Title :
Section Order :
10179
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02845-5&doi=10.1016/j.jval.2022.09.641